One woman turns to Reddit after she's been paying to store her boyfriend’s broken car for months. But after watching him ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month ...

Hims & Hers Health partnered with Novo Nordisk earlier this year, only for that to unravel shortly afterward due to ...

Hims & Hers (HIMS) stock in focus as the company faces a growing number of lawsuits following Novo Nordisk's (NVO) decision ...

A woman shares how her dad expects her to house her cousin during a big move to the UK, but she refuses, sparking a family ...

Hims & Hers Health recurring revenue grew 111% YoY, boosted by personalization and chronic care. Forecasting $2.35B revenue ...

Chatbots can get scary if you suspend your disbelief. But MJ Cocking didn’t — and wound up in a relationship that was strangely, helpfully real.

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

It's the first prescription hair regrowth gummy to hit the market, and it offers women a more convenient way to stay ...

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $47.60, moving -5.52% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.14%. On ...

When Dolly Parton was writing "9 To 5" she couldn't play her guitar because she was filming on set. So, her acrylic nails came in handy.